Clinical Trial Update: Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating apremilast for active psoriatic arthritis using clinical assessments and a joint-periarticular-nail ultrasound index to measur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• OTEZLA (apremilast)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Arthritis; Psoriasis (Etiology) | Phase 3 | Status: UNKNOWN